DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED (02348)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Shaojun | 08-Jan-18 | 16-Feb-22 | CEO | Due to intention to focus on his other business | |
| 16-Feb-22 | ED | Due to intention to focus on his other business | |||
| 18-Apr-16 | 08-Jan-18 | CEO, Non-Dir | |||
| Choi Jacky Tat Ying | 30-Sep-04 | 24-May-18 | INED | ||
| Dong Shao Zhi | 16-Jul-04 | 01-Jan-07 | CEO, Non-Dir | ||
| Ede Ronald Hao Xi | 01-Jul-17 | INED | |||
| 15-Jun-15 | 01-Jul-17 | NED | |||
| Gao Yi | 01-Jan-07 | 09-Mar-14 | CEO | ||
| He Yuyan | 01-Jun-14 | FC | |||
| Huang Dongmei | 09-Mar-14 | 01-Mar-15 | CEO, Non-Dir | ||
| Hung Yung Lai | Co-Fdr, ED | ||||
| Lam Joan Ming Yee | 25-May-18 | INED | |||
| Lam Kam Wah | 01-Jun-03 | 22-Apr-05 | ED | ||
| Lee Dannis Cheuk Yin | 25-Nov-03 | 10-Jan-07 | INED | ||
| Leung Hong Man | 01-Nov-05 | NED | |||
| Li Kei Ling | 18-Apr-16 | Ch, Co-Fdr | |||
| 01-Mar-15 | 18-Apr-16 | Ch, CEO, Co-Fdr | |||
| 01-Mar-15 | Ch, Co-Fdr | ||||
| Li Tung Ming | 14-Jan-04 | 23-Feb-18 | ED | ||
| Lo Tony Tung Sing | 01-Oct-10 | INED | |||
| Luk Olivia Wai Mei | 01-Oct-04 | CoSec, QA | |||
| Pan Xue Tian | 01-Jun-03 | 01-Jul-17 | INED | ||
| Pang Kit Ling | 01-Oct-04 | CoSec | |||
| Sik Gary Siu Kwan | 10-Jan-07 | 09-Jul-10 | INED | ||
| 15-Sep-03 | 13-Jan-04 | NED | |||
| 01-Sep-03 | 15-Sep-03 | INED | |||
| Wang Gui Guo | 01-Jun-03 | 25-Nov-03 | INED | ||
| Wu Jihong | 01-Jun-14 | FC | |||
| Wu Weixian | 16-Feb-22 | 11-Sep-24 | CEO, Non-Dir | To focus on his other personal commitments | |
| Xu Kehan | 17-Mar-04 | 18-Mar-07 | FD | ||
| Yu Liwei | 13-Sep-24 | CEO, Non-Dir | |||
| Zhang Jing Xing | 16-Jul-04 | 09-May-06 | ED | ||
| 01-Jun-03 | 16-Jul-04 | Pres |